| Literature DB >> 26137138 |
Qinghua Yao1, Ting Fu2, L U Wang2, Yuebiao Lai2, Yuqi Wang2, Chao Xu2, Lulu Huang2, Yong Guo3.
Abstract
The present study identified that ω-3 long chain polyunsaturated fatty acids (ω-3 PUFAs), docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) demonstrate anti-proliferative effects in lung cancer A549 cells. MTS and cytotoxicity assays were conducted to confirm that ω-3 PUFAs induced cell death. Autophagy-associated gene and signaling pathways were also detected. Microtubule-associated protein light chain 3 (LC3) expression was found to be increased subsequent to treatment with DHA and EPA, and the expression of LC3-II was particularly increased. mRFP-GFP-LC3 fluorescence staining and p62 expression levels were used to detect autophagic flux. The present results indicate that DHA and EPA block autophagic flux, suggesting autophagosome accumulation. Subsequent to treatment with DHA and EPA, which interfered with autophagosomes, the expression of Beclin 1 was significantly decreased, while the expression of phosphorylated Akt and phosphorylated mammalian target of rapamycin was significantly increased. Therefore, DHA and EPA exert anti-proliferative effects by inhibiting autophagy in A549 cells, which highlights the potential of DHA and EPA for use in the prevention or treatment of lung cancer.Entities:
Keywords: Akt/mammalian target of rapamycin; autophagy; ω-3 long chain polyunsaturated fatty acids
Year: 2015 PMID: 26137138 PMCID: PMC4473716 DOI: 10.3892/ol.2015.3110
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967